Clinical lab and drug development giant LabCorp announced this morning a new deal that will streamline its adoption of virtual clinical trials.
The company's drug-development-focused contract research organization (CRO), Covance, will use digital clinical trial software-maker Medable's platform to fuel its patient and site interface. This will allow participants easy access to clinical trial apps...
With all the recent technological approaches to clinical trials as of late, it’s clear that the notoriously long, expensive and often inefficient traditional process could use an update. From AI-powered matching platforms to increasingly sophisticated software to streamline data collection during trials, the space is getting busier.
Palo Alto-based monARC Bionetworks is one of the latest to make...
New York City-based ProofPilot, a startup creating technology to help anyone launch a randomized control trial, has re-launched its clinical trial product.
The software-as-a-service product is available to academic and clinical researchers as well as individuals, non-profits, and community groups. There are a range of versions at different price points, with the lowest being free and the highest...
Los Angeles-based mobile clinical trials company Science 37 has raised $6.5 million from Lux Capital and dRx Capital, a joint venture of Qualcomm and Novartis that launched in January.
The funding will help the company develop and roll out its novel clinical trial operating model, which uses mobile technology to allow patients to participate in the trial from their homes. The company draws on ...
When Apple first announced ResearchKit, it was met with a fair amount of skepticism about whether the data collected via smartphones would be robust enough to be useful. But just a few scant months after that announcement, it seems many in healthcare are at least paying attention to the possibilities of smartphone-based data collection in general and ResearchKit in particular.
Last week the...
The FDA approved its first fully remote clinical trial in 2012, but that attempt, by Pfizer and Exco InTouch, ended up folding and plans for a mulligan never came to fruition. Now Sanofi is backing another attempt at a fully remote trial, this time in Europe. Scotland-based eClinicalHealth will run the trial, called the VERKKO trial.
"This whole mechanism of doing studies in this manner is being...
